神经分泌生物科学 NBIX 深 沪
等待开盘 12-20 09:30:00 美东时间
144.94
+3.100
+2.19%
华盛通- 最 高160.18
- 今 开142.97
- 成交量 98.87万股
- 最 低 140.6669
- 昨 收 141.84
- 总市值 138.53亿
- 52周最高 160.18
- 市盈率 静 158.37
- 换手率 1.03%
- 52周最低 84.23
- 委 比 96.49%
- 总股本 9557.67万
- 历史最高 160.18
- 量 比 0.91
- 振 幅 13.76%
- 历史最低 1.10
- 每 手 1
- 风险率 15.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Neurocrine's Depression Drug Fails Phase 2 Goal But Shows Encouraging Safety Profile
Neurocrine's Phase 2 trial of NBI-1070770 in major depressive disorder missed its main goal but showed good safety and strong Q3 financial results.
11-12 01:51
Earnings Scheduled For October 28, 2025
Companies Reporting Before The Bell • PayPal Holdings (NASDAQ:PYPL) is expected...
10-28 19:11
StoneX Group Inc. Announces Pricing of $625.0 Million of Senior Secured Notes due 2032
StoneX Escrow Issuer LLC has priced a $625.0 million offering of 6.875% Senior Secured Notes due 2032 to fund the company's acquisition of R.J. O'Brien.
06-23 20:52
Neurocrine Biosciences Provides Update on ERUDITE™Phase 2 Data For Luvadaxistat
Second Phase 2 Study for Luvadaxistat Fails to Meet Primary Endpoint as Potential Treatment for Cognitive Impairment Associated with SchizophreniaResults Confounded by Variability in Cognition Measures Across Population
2024-09-13 04:11
Decoding 19 Analyst Evaluations For Neurocrine Biosciences
During the last three months, 19 analysts shared their evaluations of Neurocrin...
2024-09-09 23:01
Barclays Maintains Overweight on Neurocrine Biosciences, Lowers Price Target to $160
Barclays analyst Carter Gould maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Overweight and lowers the price target from $180 to $160.
2024-09-09 21:41
Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
10 worst performing large-cap stocks in August: Super Micro, Dollar General, Snap, PDD Holdings, Intel, Tencent Music, Gold Fields, Charles River, Moderna, Neurocrine Biosciences.
2024-09-09 01:05
Dollar General, Temu Parent PDD And Super Micro Computer Are Among Top 10 Large Cap Losers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio? Dollar General Corporation (NYSE:DG) shares dipped 32.42% after the company reported worse-than-expected second-quarter earnings and sales and lowered its 2024 guidance. Many analysts cut the price tar...
2024-09-02 21:55
Neurocrine Biosciences' Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst Upgrades Stock
Wednesday, Neurocrine Biosciences, Inc. (NASDAQ: NBIX) topline data for its Phase 2 clinical study of NBI-1117568 (NBI-‘568) in adults with schizophrenia. The new data showed that the once-daily 20 mg dose of NBI-‘568 induced an average 18.2-point reduction from baseline in the Positive and Negative...
2024-08-30 01:22
NVIDIA To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. B of A Securities cut the price target for PVH Corp. (NYSE:PVH) from $133 to $130. B of A Securities analyst H...
2024-08-29 20:45
